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Summary 
Posterior patterning in Drosophila embryos is gov- 
erned by nanos (nos), which acts by repressing the 
translation of maternal transcripts of the hunchback 
(hb) gene. Sites in hb mRNA that mediate this repres- 
sion, named nanos response elements (NREs), have 
been identified. However, we know of no evidence of 
a direct interaction between nos, or any other protein, 
and the NRE. Here, we show that two proteins present 
in embryonic extracts, neither one nos, bind specifi- 
cally to the NRE in vitro. Furthermore, we show that 
binding in vitro correlates with NRE function in vivo. 
One of the NRE-binding factors is encoded by pumilio 
(pum), a gene that, like nos, is essential for abdominal 
segmentation. These and other observations suggest 
that pum acts by recognizing the NRE and then recruit- 
ing nos. Presumably, the resulting complex inhibits 
some component of the translation machinery. 
Introduction 
During the syncytial development of Drosophila melano- 
gaster embryos, two determinants localized to opposite 
poles of the egg organize most of the anteroposterior pat- 
tern (FrohnhSfer et al., 1986; FrohnhSfer and N(~sslein- 
Volhard, 1986; Lehmann and NL~sslein-Volhard, 1986). At 
the anterior, bicoid(bcd) mRNA is anchored to the cortical 
cytoplasm (Frigerio et al., 1986; St Johnston et al., 1989), 
while at the posterior, nanos (nos) mRNA is associated 
with the pole plasm, which contains the germline determi- 
nants (Wang and Lehmann, 1991; Ephrussi and Lehmann, 
1992; Smith et al., 1992). Following fertilization, each of 
these transcripts gives rise to a gradient of protein emanat- 
ing from the appropriate pole of the embryo (Driever and 
NLissiein-Volhard, 1988; Ephrussi and Lehmann, 1992; 
Smith et al., 1992). 
The mechanism by which the bcd gradient provides po- 
sitional information is well established. In vivo, bcd regu- 
lates the zygotic transcription of hunchback (hb) (as well 
as other genes) (Tautz, 1988; Simpson-Brose et al., 1994; 
Cohen and JL~rgens, 1990; Finkelstein and Perrimon, 
1990). The bcd protein contains a homeodomain DNA rec- 
ognition motif and a distinct ranscriptional activation do- 
main. In embryos, bcd binds to specific sites in the pro- 
moter region of target genes and stimulates their 
transcription (Driever and NLisslein-Volhard, 1989; Struhl 
et al., 1989). 
In contrast, the mechanism of nos action is less well 
understood. In the preblastoderm embryo, the nos gradi- 
ent generates an opposing gradient of hb by blocking 
translation from maternal hb transcripts (Tautz, 1988; 
Wharton and Struhl, 1991). Genetic experiments have 
demonstrated that these transcripts are the only signifi- 
cant regulatory target of nos in the embryo (Halskamp et 
al., 1989; Irish et al., 1989; Struhl, 1989). The sites in hb 
mRNA that mediate nos activity, called nanos response 
elements, or NREs, have been identified (Wharton and 
Struhl, 1989); however, we know of no evidence demon- 
strating a direct interaction of nos with these sites. Further- 
more, the nos protein sequence bears no obvious homol- 
ogy to known RNA-binding proteins (Wang and Lehmann, 
1991). 
Recently, another factor that is required specifically for 
posterior patterning has been identified. In the absence 
ofpumilio (pum) function (Lehmann and N~ssiein-Volhard, 
1987), hb is expressed uniformly throughout the posterior 
of the embryo; in consequence, the embryo develops no 
abdominal segments (Barker et al., 1992). The nos and 
pum mutant phenotypes therefore are indistinguishable 
in this respect, and it has not been possible to determine 
the order of action of one with respect to the other. The 
sequence of pum suggests little about its function, and 
pum protein is distributed uniformly throughout the cyto- 
plasm of the preblastoderm embryo (Macdonald, 1992). 
Pum generally has been consi3ered to act as a cofactor 
in the repression of hb translation, with nos providing the 
spatial information as well as the molecular specificity to 
the reaction. 
Translational regulation of maternal messages is 
thought o play a significant role during development in 
many organisms, including mice (Vassalli et al., 1989), 
Xenopus laevis (e.g., Klein and Melton, 1994), and Caeno- 
rhabditis elegans (Ahringer and Kimble, 1991; Goodwin 
et al., 1993; Lee et al., 1993; Wightman et at., 1993). How- 
ever, in many of these cases, the trans-acting regulators 
have not been identified, or their interactions with cis- 
acting targets in the appropriate mRNA have not been 
well defined. In this report, we characterize factors in em- 
bryonic extracts that bind to NRE sequences, in order to 
understand better the mechanisms by which hb translation 
is regulated. We describe some properties of two factors 
present in embryonic extracts, neither one nos, that bind 
specifically to different regions of the NRE. Using mutant 
NREs, we show that the binding of these factors in vitro 
correlates with NRE function in vivo. Several lines of evi- 
dence lead to the conclusion that one of these factors is 
pum, and that both pum and a 55 kDa factor bind to hb 
mRNA in the absence of nos activity. These results sug- 
gest a model for NRE function in which the RNA is recog- 
nized by pum and perhaps by the 55 kDa factor. We further 
suggest that the NRE-bound proteins serve to recruit nos, 
which then interacts with the translation machinery. 
Results 
Embryonic Proteins That Bind Specifically 
to the hb NRE 
To identify factors that interact with the regulatory target 
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Figure 1. Two Proteins Bind Specifically to the NRE 
Shown are the results of a UV cross-linking experiment on the left and 
of a gel mobility shift experiment on the right. Binding assays were 
performed in the presence of 100 mM KCI as described in the Experi- 
mental Procedures, using cytoplasmic extracts from wild-type em- 
bryos and either RNA molecules bearing a single copy of the wild-type 
NRE (sense), or molecules bearing sequences complementary to the 
NRE (antisense). The bold arrows labeled as A and B indicate the two 
protein-RNA complexes that we observe reproducibly in both assays, 
and the arrowhead labeled as C indicates an NRE-nonspecific complex 
that is barely detectable here (but is prominent in Figure 5, for exam- 
ple). Note that the 55 kDa NRE-binding protein also binds weakly to 
the antisense RNA and other control RNAs (see Figure 5, for example). 
For the UV cross-linking panel, the numbers indicate the sizes of pro- 
tein molecular weight markers in kilodaltons. For the gel mobility shift 
panels, minus and plus indicate that reaction mixtures were incubated 
in the absence and presence of embryonic extract, respectively. 
in hb mRNA, we prepared crude, unfractionated extracts 
containing cytoplasmic proteins from early Drosophila em- 
bryos. We also prepared small radiolabeled RNAs, each 
containing a single copy of an NRE that confers nos- 
dependent regulation in vivo. Protein and RNA solutions 
were incubated, and then protein-RNA interactions were 
detected by either of two methods: covalent transfer of 
32p to proteins following ultraviolet (UV) irradiation, or elec- 
trophoretic resolution f complexes in nondenaturing poly- 
acrylamide gels. 
As shown in Figure 1, two proteins with approximate 
molecular weights of 55 kDa and 165 kDa bind to the NRE, 
as assayed by UV cross-linking. In control experiments 
using similar RNA molecules that lack an NRE, binding 
of the 165 kDa protein is undetectable, and binding of the 
55 kDa protein is dramatically reduced. Although we have 
not optimized the reaction conditions, two observations 
proved to be particularly useful for further characterization 
of the binding proteins. First, the 165 kDa activity appears 
to be relatively labile, as it is not detectable when xtracts 
are prepared in the absence of protease inhibitors (data 
not shown). Second, the 55 kDa binding activity is ob- 
served in the presence of 100 mM KCI but not in its ab- 
sence (data not shown). 
The results of gel mobility shift assays are consistent 
with those obtained in UV cross-linking experiments. As 
shown in Figure 1, we have reproducibly resolved two 
NRE-specific protein-RNA corn plexes. Several lines of ev- 
idence support he idea that the complex identified as A 
in Figure 1 contains the 55 kDa protein, whereas complex 
B contains the 165 kDa protein. First, omission f KCI or 
protease inhibitors from the reaction mixture dramatically 
diminishes the quantity of complexes A and B, respec- 
tively. Second, isolation of complex A followed by UV irra- 
diation results in the covalent transfer of 32p to a protein 
that comigrates with the 55 kDa factor (data not shown; 
see Experimental Procedures). Finally, the results of ex- 
periments using mutant NREs (described below) are con- 
sistent with the idea that binding of the 55 kDa factor gen- 
erates complex A and binding of the 165 kDa factor 
generates complex B. 
We do not see evidence for the existence of a higher 
order complex consisting of both proteins bound to he 
same RNA molecule. Such a complex might either be un- 
stable in our gel system or present at undetectably low 
levels. Alternatively, it might resolve poorly from either 
complex B or complex C; the latter, which we do not ob- 
serve reproducibly, migrates more slowly than B and is 
not NRE specific (Figure 1; see Figure 5). 
The 165 kDa Protein Is Pum 
The pum protein in embryos has an approximate molecu- 
lar weight of 160 kDa (Macdonald, 1992), which led us to 
consider whether the protein component of the 165 kDa 
covalent protein-RNA complex might be pure. This sug- 
gestion, that pum might bind irectly to the NRE, was 
somewhat heterodox, since it is an ubiquitous rather than 
a spatially restricted protein; in addition, pum protein has 
none of the well-characterized RNA-binding motifs (Burd 
and Dreyfuss, 1994). 
We first investigated the possibility that pum binds di- 
rectly by examining the NRE-binding activities in extracts 
prepared from pum mutant embryos. As indicated in Fig- 
ure 2A, the 165 kDa NRE.binding activity is not present 
in these pure- extracts, although the 55 kDa activity is 
present at levels comparable to those in wild-type extracts. 
Western blots probed with pum-specific antibodies dem- 
onstrated that thepum- embryo extracts contain no detect- 
able full-length protein (data not shown). Thus, production 
of the 165 kDa factor is dependent on pure function in 
vivo. 
We next asked whether the 165 kDa factor is recognized 
by pum-specific antibodies in v tro. As shown in Figure 2B, 
preincubation of wild-type embryo extracts with anti-pum 
antibodies, but not control antibodies, blocks the binding 
of the 165 kDa protein to the NRE; binding of the 55 kDa 
protein is unaffected by either type of antibody. The sim- 
plest interpretation of these observations is that the 165 
kDa factor is pum. 
To prove that pum binds directly to the NRE, we pre- 
pared extracts containing pum protein from two sources: 
COS cells transiently transfected with DNA that directs the 
expression of pure, and reticulocyte lysates programmed 
with synthetic pum message. As shown in Figure 2C, both 
extracts contain an activity that is indistinguishable from 
the activity of the 165 kDa factor present in embryonic 
extracts; in contrast, control extracts (prepared from 
Pumilio Binds to hunchback mRNA 
749 
A 
E E 
E E 
-~4o 
- -87 
, . - im.  
-48  
:i!i!!iiiiii!ii!iiii! ~
Figure 2. Pumilio Binds to the NRE 
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(A) pum- embryos lack the 165 kDa NRE-binding activity. Shown are the results of gel mobility shift (left) and UV cross-linking (right) experiments 
in which RNA bearing a wild-type NRE was incubated with either no extract (minus), extract prepared from wild-type embryos (wt), or extracts 
prepared from embryos derived from two different types of pum- females (pum-; see Experimental Procedures for details). The arrows point to 
the complexes formed by binding of pum (top) and the 55 kDa factor (bottom). The NRE-nonspecific complex C is clearly visible in lanes 2-4 of 
the gel shift experiment. Note that the gel shift experiment was performed in the absence of KCI. 
(B) Pum-specific antibodies block binding of the 165 kDa protein. Wild-type embryo extracts were preincubated in the absence of KCI with serum 
containing pum-specific antibodies (anti-pure) or control serum (anti-control) containing antibodies that react weakly with an irrelevant protein, 
tailless. These pretreated extracts were then used in a gel mobility shift experiment, the results of which are shown. The arrows point to the 
complexes formed by binding of pum (top) and the 55 kDa factor (bottom). Note that the addition of serum slightly enhances binding of the 55 
kDa factor to a variable extent; we assume that this is caused by the presence of salt(s) in the serum, as no similar effect is observed when the 
reaction mixture contains 100 mM KCI. 
(C) Pum produced in COS cells or reticulocyte lysates binds to the NRE in the absence of other Drosophila proteins. Shown are the results of 
UV cross-linking experiments in which NRE-bearing RNA was incubated with extracts prepared from embryos (lane 1), extracts prepared from 
transiently transfected COS cells (lanes 2 and 3), or the products of in vitro protein synthesis in rabbit reticulocyte lysates (lanes 4 and 5). Above 
each lane, plus indicates the presence in embryos, COS cells, or lysate (as appropriate) of mRNA encoding pum, and minus indicates its absence. 
The arrows point to the complexes formed by binding of pum (top) and the 55 kDa factor (bottom), and the numbers at the right indicate the sizes 
of protein molecular weight markers in kilodaltons. Note that both COS cells and the reticulocyte lysate contain a protein that binds to the NRE-bearing 
RNA and is similar in size to the 55 kDa factor in embryonic extracts. We do not know whether this binding is NRE specific. 
(D) Pum binds directly to the NRE. Rabbit reticulocyte lyaates were programmed with RNA encoding either wild-type pum (wt) or two truncation 
derivatives (A2 and 43). The resulting lysates were then used in UV cross-linking experiments as described above. The proteins encoded by 
these derivatives, and their molecular weights, are indicated schematically below. Pumb.2 was constructed by deletion of a SmaI-Smal fragment 
in pum, and PumA3 was constructed by deletion of sequences distal to a Bglll site in pum. 
mock-transfected COS cells or unprogrammed reticulo- 
cyte lysates) contain no such activity. Finally, we have 
shown that truncated derivatives of pum produced in retic- 
ulocyte lysates bind to the NRE in UV cross-linking assays 
(Figure 2D), demonstrating that the pum-NRE interaction 
is direct. We conclude that pum binds specifically to the 
NRE. Furthermore, it can do so in the absence of other 
Drosophila proteins, although we cannot exclude the pos- 
sibility that both extracts contain auxiliary factors that sub- 
stitute for similar factors in the Drosophila embryo. 
The 55 kDa Factor Is Not Nos 
We next asked whether the 55 kDa factor is nos. The nos 
protein in embryos consists of a heterogeneous collection 
of molecules with a median molecular weight of approxi- 
mately 47 kDa (Gavis and Lehmann, 1994). Thus, the pro- 
tein component of the 55 kDa protein-RNA complex could 
De nos. However, three lines of evidence demonstrate that 
this is not the case. 
First, the amount of 55 kDa activity we detect in embry- 
onic extracts is insensitive to changes in the intracellular 
level of nos. We prepared extracts from mutant embryos 
that contain dramatically different levels of nos protein; 
relative to wild-type embryos, embryos from nos  BN females 
contain almost undetectable levels of nos, whereas em- 
bryos from females carrying an altered nos transgene 
(Gavis and Lehmann, 1992) substantially overproduce nos 
protein (Figure 3). Strikingly, the levels of 55 kDa binding 
activity in these two mutant extracts and in a wild-type 
extract are essentially indistinguishable. 
Second, embryonic extracts prepared from oskar  (oak)- 
females contain levels of 55 kDa binding activity that are 
essentially indistinguishable from those in wild-type ex- 
tracts (data not shown). Previous studies have shown that 
oak function is required for the localization of nos  mRNA 
and the accumulation of nos protein in embryos (Smith et 
al., 1992; Ephrussi and Lehmann, 1992; Gavis and Leh- 
mann, 1994). 
Third, we prepared extracts from nos Rc, nosRD, nos ew, 
and nos '7 mutant flies. These alleles have different proper- 
ties in vivo (Lehmann and Nesslein-Volhard, 1991; Wang 
et al., 1994) and have different types of lesions (data not 
shown). Nevertheless, each mutant extract contains nor- 
mal levels of a 55 kDa NRE-binding activity that is indistin- 
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Figure 3. The 55 kDa Factor Is Not Nos 
Shown on the left is a Western blot in which nos protein is detected 
with specific antibodies. Extracts were prepared from embryos derived 
from nos BN mutant females (lane 1), females expressing an altered 
nos transgene (nb) that causes the ectopic expression of nos (lane 2; 
see Gavis and Lehmann, 1992), or wild-type embryos (lane 3). The 
bracket at the left indicates that the nos in wild4ype embryos consists 
of a heterogeneous population of molecules, as een by Gavis and 
Lehmann (1994). The prominent band near the top of the photograph 
is a cross-reacting protein. The sizes of protein molecular weight mark- 
ers in kilodaltons are indicated at the right. 
Shown on the right is the result of a gel mobility shift assay using 
aliquots of the same extracts. (In lane 1, minus indicates incubation 
in the absence of any extract.) The arrows point to the complexes 
formed by binding of pure (top) and the 55 kDa factor (bottom). Note 
that the relative amount of pure activity that we recover in different 
preparations of embryonic extract is somewhat variable, and we as- 
sume that this variability accounts for the small differences seen here. 
t inguishable from that in wild-type extracts (data not 
shown). 
Taken together, these observations show that the 55 
kDa factor is not nos. Furthermore, since the binding of 
the 55 kDa factor or pure occurs with equal efficiency in 
the presence and absence of nos function, it is unlikely 
that nos is required in order to stabilize the interaction 
between either of these factors and the NRE. Finally, we 
note that we have been unable to detect a specific interac- 
tion between nos and the N RE by using extracts containing 
high levels of nos protein prepared either from embryos 
or from transfected COS cells (data not shown). 
Binding of Pum to the NRE Correlates 
with Its Function In Vivo 
While the results described above show that pure and the 
55 kDa factor bind specifically to the wild-type NRE in 
vitro, they do not demonstrate that these interactions are 
physiologically relevant. To address this issue, we tested 
the activities of a collection of mutant NREs in vitro and 
in vivo. Each of these sites bears a tandem dinucleotide 
substitution (Figure 4A). To assay NRE activity in vitro, 
we performed UV cross-linking and gel retardation experi- 
ments using wild-type embryonic extracts and synthetic 
NRE-bearing RNA (Figure 4B; see Figure 5). To assay 
activity in vivo, we determined whether each mutant NRE 
permits normal abdominal segmentation when substituted 
for the wild-type NREs in maternal hb mRNA (see Figure 
6). Previous experiments have shown that the wild-type 
NREs mediate efficient translational repression by nos, 
A 
5 6 i 9 4 lo 2 v s 
A U U A U U U ~ G A A ~ A U A A G C C  
GG GG CC CC CC CU 
CA AC 
GC 
B 
+ 1 2 3 4 5 6 + 7 8 9 10 
"--m" 
--140 
---87 
Figure 4. Binding of Pure and the 55 kDa Factor to Mutant NREs In 
Vitro 
(A) Identities of the mutant NREs. Shown is the sequence of one of 
the wild-type NREs present in hb mRNA; when substituted for the 
endogenous ites, the resulting hb mRNA derivative is regulated in a 
manner indistinguishable from wild-type hb mRNA (Wharton and 
Struhl, 1991). Therefore, we have used this site as the basis for experi- 
ments in this report. Each mutant NRE (identified by number above) 
contains a tandem dinucleotide substitution (identified below). NRE3 
is a compound mutant, containing the four substitutions present in 
NRE1 and NRE2. 
(B) UV cross-linking assays. Shown are the results of UV cross-linking 
experiments in which aliquots of wild-type embryonic extract were 
incubated with RNA molecules bearing wild-type (plus) or various mu- 
tant NREs, as indicated at the top. Note that the figure is a composite 
of two experiments, with mutants 1-6 analyzed on one gel, and mu- 
tants 7-10 analyzed on another. Note also that the left part of the 
figure is derived from two different autoradiographic exposures of the 
same gel. Two additional points are as follows. First, the binding of 
pum to NREg, which is weak in this experiment, is indistinguishable 
from binding to NRE ÷ in the presence of 0 mM KCI (data not shown). 
Second, NRE5 and NRE6 bind weakly to both proteins in this assay 
and in gel mobility shift assays (data not shown). The arrows point to 
the complexes formed by binding of pum (top) and the 55 kDa factor 
(bottom), and the sizes of protein molecular weight markers in kilodal- 
tons are indicated at the right. 
resulting in the formation of a steep hb protein gradient 
in the posterior and the development of a normal comple- 
ment of eight abdominal segments (Wharton and Struhl, 
1991). Conversely, mutant NREs mediate inefficient re- 
pression, resulting in the formation of a shallow hb protein 
gradient and the development of fewer abdominal seg- 
ments. 
In summary, we observe (with a single exception) the 
following qualitative correlation: mutations that interfere 
specifically with the binding of either pure or the 55 kDa 
factor reduce NRE function in vivo, whereas mutations 
that have no specific effect on the binding of either factor 
have no detectable effect on NRE function (Table 1). The 
NRE mutations are divided into four classes, which are 
discussed in turn below: mutations that affect pure bind- 
ing, a single mutation that affects binding of the 55 kDa 
Pumilio Binds to hunchback mRNA 
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Table 1. Activity of Mutant NFIEs In Vitro and In Vivo 
Pum Binding 55 kDa Binding Activity 
Mutant In Vitro In Vitro In Vivo 
NRE1 + - - 
NRE2 - + - 
NRE3 - - ND 
NRE4 + + + 
NRE5 _a _, + 
NRE6 _a _~ + 
NRE7 - + - 
NRE8 - + - 
NRE9 _b + _b 
NRE10 + + - 
For each mutant NRE, the table indicates the ability of the mutant to 
bind pum and the 55 kDa factor in vitro and to permit normal abdominal 
segmentation when substituted for the endogenous NREs in maternal 
hb mRNA. Binding activity, which was assessed by considering the 
results of both UV cross-linking and gel mobility shift experiments 
(Figures 4 and 5; data not shown), is scored relative to the binding 
activity of the wild-type NRE as either similar (plus) or significantly 
reduced (minus). Activity in vivo is scored as plus if maternal expres- 
sion of the appropriate hb-NRE-containing mRNA leads to the develop~ 
ment of a full complement of eight abdominal segments and is scored 
as minus if abdominal segmentation is disrupted (Figure 6). NRE3 (a 
compound mutant bearing the four substitutions present in both NRE1 
and NRE2) was not tested in vivo. Thus, with the exception of NRE10, 
the activity of each site s correlated in vivo and in vitro. 
In these instances, NRE5 and NRE6 bind weakly to both proteins 
and thus exhibit no specific binding defect in vitro. 
b In these instances, the defects associated with NRE9 are weak. 
factor, mutations that nonspecifically affect the binding 
of both proteins, and mutations that affect the binding of 
neither protein. 
Mutations That Affect Pum Binding 
In vitro, pum does not bind detectably to NRE2, NRE7, 
or NRE8; it binds weakly to NRE9, and this binding is 
salt sensitive, unlike binding to the other mutants or the 
wild-type NRE (see Figures 1 and 4B). In contrast, all four 
of these sites bind the 55 kDa factor as well as does the 
wild-type NRE. Thus, the mutations in these four sites 
appear specifically to affect the binding of pum, sug- 
gesting that pum and the 55 kDa protein have at least 
partially distinguishable binding sites within the NRE. 
As expected if pum binding is important in vivo, we find 
that none of these four sites permit normal abdominal de- 
velopment. The transgene directing expression of each 
of these hb mRNA derivatives causes dominant female 
sterility and embryonic lethality. The lethality is due to de- 
fects in abdominal segmentation: embryos containing the 
hb-NRE2 or hb-NRE7 mRNA typically develop no abdomi- 
nal segments; embryos containing the hb-NRE8 mRNA 
typically develop four segments; and embryos containing 
the hb-NRE9 mRNA typically develop six or seven seg- 
ments (see Figure 6). We have not measured the affinity 
of purified pum for these sites; thus, in general, we cannot 
correlate the extent of abdominal segmentation with the 
relative affinity of each site for pum. However, it is notable 
that among these mutants, NRE9 exhibits the weakest 
defects, both in vitro and in vivo. Taken together, the sim- 
plest interpretation of these results is that binding of pum 
to the NRE is essential for normal abdominal development. 
A Mutation That Affects Binding 
of the 55 kDa Factor 
In UV cross-linking experiments, the 55 kDa factor binds 
weakly to NRE1, whereas binding of pure to this site appar- 
ently is unaffected (Figure 4B), However, binding of the 
55 kDa factor is reduced only slightly as measured in this 
assay, so we further investigated the properties of NRE1 
in gel mobility shift experiments. As shown in Figure 5A, 
the 55 kDa factor binds very poorly to NRE1, whereas it 
binds normally to NRE2. Taken together, these observa- 
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Figure 5. NRE1 Binds Weakly to the 55 kDa 
Factor and Binds Normally to Pure 
(A) Shown are the results of a gel shift experi- 
ment using extract prepared from wild-type em- 
bryos and RNAs bearing various NREs (indi- 
cated at the top). In each pair of lanes, minus 
indicates that extract was omitted from the re- 
action mixture, and plus indicates that i  was 
included. The arrows point to the complexes 
formed by binding of pum (top) and the 55 kDa 
factor (bottom). In addition, pum-dependent 
complexes are marked by arrowheads within 
the figure. The NRE-nonspecific complex C, 
which is described in the text, is identified only 
in the NRE ÷ control lanes, although it is present 
in the other lanes also. Note that pure binding 
to NRE2 is undetectable and that pure binding 
to NRE1 is comparable to its binding to NRE +, 
(B) Shown are the results of a binding competi- 
tion experiment inwhich various unlabeled RNA molecules (identified at the top) were used to compete the binding of proteins in embryonic extract 
to labeled NRE÷-bearing RNA. The control' RNA was prepared by transcribing pSP73 polylinker sequences (see Experimental Procedures for other 
details). Where appropriate, the molar ratio of competitor to tester RNA was 250 in one reaction and 1000 in the other. In other experiments, lower 
concentrations of NRE +- and NREl-bearing RNA compete pum binding to the same extent (data not shown). Note that all RNA molecules we 
have tested compete binding of the 55 kD~a factor, although we find that NRE-bearing RNA does so more effectively than does non-NRE-bearing 
RNA. 
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Figure 6. Activity of Mutant NREs In Vivo 
Each photograph shows the segmentation pattern of a typical embryo 
that contained uring its early development a particular maternal hb 
mRNA derivative. In each such derivative, two copies of the NRE 
identified at the left were substituted for the endogenous hb NREs 
(see Experimental Procedures). In the ventrolateral spects hown, 
each abdominal segment is marked by a characteristic band of thick 
hairs that are readily visible indark field. For each NRE, the median 
number of abdominal segments that develops i  as follows: NRE2 and 
NRE7, 0 (although some embryos contain a disorganized patch of 
abdominal hairs); NRE10, 2.5; NRE1 and NRE8, 4.5; NRE9, 7; NRE +, 
NRE4, NRE5, and NRE6, 7.5. Note that expression of the NRE2-hb, 
NRE7-hb, and NRE10-hb mRNA derivatives causes completely pene- 
trant dominant female sterility, all of the progeny dying with fewer than 
the normal complement of eight abdominal segments. Note also that 
almost all embryos bearing NREI-hb or NRE8-hb mRNA derivatives 
die with severe abdominal defects like those shown, but that he pheno- 
type is not completely penetrant; a minority of these embryos develop 
more segments, and some lines have rare escapers that yield viable 
adults. Embryos containing NREg-hb mRNAs are viable and develop 
only weak segmentation defects; most develop into adults. Head and 
thoracic development is normal in each case. 
tions suggest that the NRE1 mutation specifically inter- 
feres with binding of the 55 kDa factor. 
To test this idea further, we performed binding competi- 
tion experiments, preincubating aliquots of wild-type ex- 
tract with a vast molar excess of various unlabeled compet- 
itor RNAs prior to the addition of 32P-labeled NRE+-bearing 
RNA. We find that the NRE1 mutant site competes the 
binding of pure as effectively as does the wild-type NRE 
(Figure 5B). This result is consistent with the idea that 
NRE1 is specifically defective in binding the 55 kDa factor, 
an important point in considering its role in vivo (see be- 
low). Two additional observations from these experiments 
are as follows. First, while the 55 kDa factor binds preferen- 
tially to the wild-type NRE, it binds weakly to control RNA 
lacking an NRE (see Figure 1 ; Figure 5) as well as to NRE1. 
Thus, the binding specificity of the 55 kDa factor appears 
to be somewhat lower than that of pure under these condi- 
tions. Second, the affinity of pure for NRE2 is negligible, 
since this mutant site does not compete pum binding to 
NRE ÷, even when present at a 1000-fold higher concentra- 
tion (Figure 5B). 
When in vivo tests are performed, we find that he NRE1 
mutant site does not permit normal abdominal develop- 
ment. As is the case for embryos containing hb mRNA 
derivatives that do not bind pum, embryos containing the 
hb-NRE1 mRNA die, typically developing four abdominal 
segments (Figure 6). Thus, nucleotides within the NRE 
that are essential for binding the 55 kDa factor are essen- 
tial for normal development. Proof that binding of the 55 
kDa factor is essential in vivo awaits genetic evidence that 
it plays a role in regulating the translation of hb mRNA. 
Mutations That Nonspecifically Affect the Binding 
of Both Proteins 
In vitro, both pure and the 55 kDa factor bind very weakly 
to NRE5 and NRE6 (see Figure 4B). This finding suggests 
either that both proteins directly contact the bases altered 
in these mutants or that the substitutions affect the binding 
of both proteins indirectly, perhaps by altering the RNA 
structure. Consistent with the idea that binding in vitro is 
sensitive to changes in RNA structure, our observations 
have shown that the addition of flanking sequences at a 
remove from the NRE can eliminate NRE-specific binding 
(data not shown). 
Embryos containing the hb-NRE5 and hb-NRE6 mRNAs 
develop a wild-type complement of eight abdominal seg- 
ments (Figure 6). Thus, the NRE5 and NRE6 mutant sites 
function in vivo as well as does the wild-type site. As the 
NRE5 and NRE6 sites are not associated with any pheno- 
type in vivo, we have not investigated their properties in 
vitro further. 
Mutations That Bind Both Proteins Normally 
The binding of both pure and the 55 kDa factor to NRE4 
and to NREt 0 is essentially indistinguishable from binding 
to the wild-type site (see Figure 4B). However, the activities 
of these mutant sites in vivo are dramatically different. 
Consistent with its properties in vitro, embryos containing 
hb-N RE4 mRNAs develop a wild-type complement of eight 
abdominal segments (Figure 6). In contrast, embryos con- 
taining hb-NRE10 mRNAs die, typically developing only 
three abdominal segments (Figure 6). The discrepancy 
between the activity of NRE10 in vitro and its activity in 
vivo suggests that our binding assays do not detect all of 
the interactions necessary for regulation of hb translation 
in vivo. 
In summary, with the exception of NRE10, every muta- 
tion tested that disrupts NRI = function in vivo disrupts spe- 
cific binding of either pum or the 55 kDa protein in vitro 
(see Table 1). Moreover, in one case (NRE9), we observe 
a qualitative correlation between the extent o which NRE 
function is reduced in vivo and the extent to which pure 
binding is disrupted in vitro. 
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Discussion 
In this report, we describe specific interactions between 
pure and the NRE, the sequence in hb mRNA that medi- 
ates its translational regulation. Furthermore, we observe 
that several mutations that block pum binding in vitro pre- 
vent normal abdominal segmentation. We conclude that 
recognition of the NRE by pum is essential in vivo. We 
also observe specific binding of a 55 kDa protein to the 
NRE and describe one mutation that disrupts this interac- 
tion in vitro and blocks normal N RE function in vivo. Finally, 
we see no evidence for a direct interaction between nos 
and the NRE; in addition, our mutational analysis of the 
NRE is consistent with the idea that most of the specific 
contacts it makes in vivo are with pum or the 55 kDa factor. 
On the basis of these observations, we suggest the fol- 
lowing speculative model for NRE function in vivo. We 
suggest that the NRE is a composite binding site for both 
pum and the 55 kDa factor. Both proteins are probably 
bound to NRE-bearing mRNA throughout he embryo, but 
this has no consequences for translation in the absence 
of nos activity. Then, in the posterior of the embryo, we 
suggest that nos is recruited to the NRE largely via weak 
protein-protein contacts with pum or the 55 kDa factor. 
Finally, nos acts (perhaps in conjunction with the other 
NRE-bound proteins)to block translation of the message. 
In this model, pum and the 55 kDa factor collaborate to 
form a landing pad for nos in the hb 3' untranslated region. 
Below, we discuss some of the evidence in support of 
these ideas, considering separately the roles of pum, the 
55 kDa factor, and nos in the regulation of hb translation. 
Role of Pum in Posterior Patterning 
Our finding that pum binds specifically to the NRE was 
unanticipated, primarily because pum is distributed 
throughout he cytoplasm of the embryo during early de- 
velopment (Macdonald, 1992). In contrast, nos is distrib- 
uted in a gradient emanating from the posterior pole; thus, 
by analogy with the anterior determinant system, it has 
generally been assumed that the spatially graded factor 
nos would recognize the NRE directly. These models left 
pure in an ill-defined role, in which it is required for efficient 
translational regulation of hb mRNA but does not neces- 
sarily contribute specificity to the repression reaction. Our 
results show that pum is a key specificity determinant, 
contributing most of the contacts involved in recognizing 
the NRE regulatory target. They also show that pure can 
bind efficiently to the NRE in the absence of other Drosoph- 
ila proteins; therefore, we imagine that it is bound to hb 
mRNA via its NREs throughout he embryonic cytoplasm. 
In addition, the sequence of pum protein (Macdonald, 
1992; Barker et al., 1992) offered no intimation that it might 
bind to a specific RNA site. The protein contains none of 
the motifs associated with traditional RNA-binding pro- 
teins such as those in heterogeneous ribonucleoprotein par- 
ticles or splicing factors, for example. Nor does it contain 
obvious homologies to less well-defined motifs that may 
mediate site recognition by other RNA-binding proteins 
(Burd and Dreyfuss, 1994). We have not yet localized the 
RNA-binding domain of pum; experiments such as that 
shown in Figure 2D suggest that noncontiguous regions 
of the protein may contribute to RNA binding (data not 
shown). As has been noted previously, the most prominent 
features of the 160 kDa pure protein are several homopoly- 
meric amino acid patches in its amino terminus as well as 
eight tandem, imperfect repeats in its carboxyl terminus. 
Presumably only part of the protein is required in order to 
recognize the NRE, leaving the remainder free to interact 
with nos, the 55 kDa NRE-binding factor, or components 
of the translation machinery. 
Role of the 55 kDa Factor in Posterior Patterning 
Our results suggest that the 55 kDa factor may be involved 
in regulating the translation of hb mRNA and thereby gov- 
erning abdominal segmentation. This idea derives from 
consideration of the properties of NRE1 in three different 
experiments. First, we find that expression of the hb-NRE1 
mRNA is not normally regulated, leading to the develop- 
ment of only half the normal number of abdominal seg- 
ments. Second, we find that the 55 kDa factor binds much 
more weakly to NRE1 than to NRE ÷ in vitro. Third, we find 
that the binding of NRE1 to pum, the only other NRE- 
binding protein we have detected, is normal in binding 
competition experiments. As outlined above, we favor a 
model in which both pum and the 55 kDa factor bind the 
NRE in vivo. However, a critical test of the role of the 55 
kDa factor awaits the isolation of mutations in the gene 
encoding this protein. 
Role of Nos in Posterior Patterning 
In the model we advance here, nos makes two main contri- 
butions to posterior patterning. First, as the only factor 
known to be distributed in a gradient in the posterior, we 
assume that it provides the positional information required 
for patterning. Second, as pum is incapable of repressing 
hb translation on its own, we assume that nos, perhaps 
in collaboration with the other NRE-bound proteins, makes 
inhibitory contacts with some component of the translation 
machinery. We believe that nos is recruited to the NRE 
largely or exclusively via protein-protein rather than spe- 
cific protein-RNA contacts. 
The argument that nos is unlikely to make extensive 
direct contacts with the NRE is based on two lines of evi- 
dence. The first is negative: we do not detect interactions 
between nos and the NRE even if the protein is overpro- 
duced in embryos or in COS cells. The second line of 
evidence involves consideration of the properties of mu- 
tant NREs in vivo and in vitro. Six of the mutants we have 
tested do not function as well as the wild-type NRE in vivo; 
of these, all but one are defective in binding to either pure 
orthe 55 kDa factor in vitro (Table 1). Thus, with the excep- 
tion of NRE10, the inactivity of the mutant sites in vivo 
can be accounted for by their inability to interact with one 
of the two NRE-binding proteins identified in this report. 
While our mutational analysis of the N RE is not exhaustive, 
we have altered 18 of its 32 bases, leaving no span of 
more than 3 nt unprobed by mutation. Thus, if nos does 
make contacts with the NRE that we cannot detect, they 
are probably either relatively nonspecific or limited to a 
few nucleotides, such as those altered in NRE10. 
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We suggest above that nos is recruited to the NRE 
indirectly, making contacts to the NRE-bound proteins. 
However, in the experiments reported here, we have been 
unable to detect interactions between nos and any pro- 
te in -NRE complex. Indeed, in gel mobil ity shift experi- 
ments using crude embryonic extracts as a source of pro- 
tein, we cannot even detect ternary complexes containing 
pure, the 55 kDa factor, and the NRE. Thus, if the addition 
of nos requires the binding of both pum and the 55 kDa 
factor to a single NRE, as we postulate, it is not surprising 
that we do not detect nos-dependent supercomplexes in 
our gel shift assays. Resolution of these issues awaits 
purification and further characterization of the NRE-binding 
proteins. 
Although it is not clear why regulation of hb translation 
might require the unparsimonious assembly of two (or 
more) proteins on the NRE, there are other cases of RNA 
regulation in which the assembly of large multiprotein com- 
plexes apparent ly is required. For example,  the sex- 
specific splicing of doublesex (dsx) RNA in Drosophila in- 
volves the binding of at least two general splicing factors 
as well as the specific factors tra and tra2 to a splicing 
enhancer (Amrein et al., 1994; Tian and Maniatis, 1993, 
1994). Perhaps combinatorial,  weak protein-protein and 
prote in-RNA interactions are used to generate highly spe- 
cific regulatory switches in each of these cases. 
NOS and Pum as Translational Repressors 
We do not yet understand the mechanisms by which nos 
and pure col laborate to block translation of hb mRNA. 
However,  several recent observations suggest that trans- 
lational control mediated by these proteins or their cog- 
nates may occur in a number of developmental  systems. 
For example,  sequences resembling NREs have been im- 
plicated in the temporal translational control of maternal 
Cyclin B (CycB) mRNA in Drosophila pole cells (Dalby and 
GIover, 1993). Also, genes with homology to nos and pure 
have been reported in Xenopus and Saccharomyces cere- 
visiae, respectively (Mosquera et al., 1993; Chen et al., 
1991). 
More intriguingly, NRE-like sequences are thought to 
confer spatial regulation on the C. elegans maternal glp-1 
mRNA, which encodes a member  of the Notch/LIN-12 
t ransmembrane receptor family (Evans et al., 1994). As 
is the case for hb in Drosophila embryos, maternal glp-1 
mRNA is uniformly distributed throughout the early C. 
elegans embryo; however, translation of the message is 
repressed in the posterior part of the embryo. An RNA 
element that includes NRE-like sequences is necessary 
and sufficient to confer this spatial regulation on microin- 
jected reporter transcripts, which led Evans et al. to sug- 
gest that a conserved nos-like activity might be present 
in the worm em bryo. The observations we report here su g- 
gest that worm homologs of pum or the 55 kDa factor 
might also play a role in regulating glp-1 translation. 
Experimental Procedures 
Strains and Reagents 
in the experiment shown in Figure 2A, the flies were heteroallelic om- 
binations of pure E~ (Bloomington Stock Center) with either In(3R)Msc 
or T(3;1)FC8 (Barker et al., 1992). Elsewhere, the following mutant 
flies were used: nos 8~ (Wang et al., 1994), nb-5 (nb; Gavis and Leh- 
mann, 1992), and Df(3R)DI x43 (Bloomington Stock Center). Wild-type 
flies were Oregon R. The rat anti-pum serum was a gift from P. Macdon- 
ald. For the control in the experiment shown in Figure 2B, we used 
serum from a rat immunized with a fragment of tailless. Rat anti-nos 
sera were generated by standard techniques (Harlow and Lane, 1988). 
Construction of NRE-Bearing Plasmids 
For testing the activity of each mutant NRE in vivo, two copies of a 
synthetic double-stranded fragment encoding the NRE were inserted 
in tandem into the unique Spel site of p2343 essentially as described 
by Wharton and Struhl (1991). 
For testing the binding activity of each mutant NRE in vitro, a single 
copy of each of the fragments described above was inserted separately 
into the unique Spel site of p4684, p4684 was generated by insertion 
of a synthetic duplex containing the Spel site of p2343 as well as 
flanking hb sequences into Bluescript KS(-) (Stratagene) between 
Sacl and Pstl, yielding a plasrnid bearing the following sequence: GAG- 
CTCACTATCATAAAGACTAGTCTGGAGAAACATCTGCAG. 
RNA Binding Assays 
Dechorionated embryos were resuspended in ice-cold extract buffer 
(25 rnM HEPES [pH 7.5], 10% sucrose, 5% glycerol, 0.1 rnM EDTA, 
1 mM DTT, 0.2 rnM AEBSF, 1 p_g/rnl aprotinin, 1 rnM benzarnidine, 10 
i~g/ml leupeptin, and 10 ~g/ml pepstatin) and homogenized. Following 
centrifugation, the supernatant was incubated with RNA as described 
below. In some cases (particularly nos Rc and nos ~° mutants), similar 
extracts were prepared from adults. Synthetic 32P-labeled RNA was 
prepared by standard procedures using EcoRl-linearized derivatives 
of p4684. Gel shift assays were performed essentially as described 
by Andino et al. (1990). Each reaction (total volume, 10 p.I) contained 
the following: embryo extract (10-30 p.g of total protein), binding buffer 
(10 mM HEPES [pH 7.9], 5 mg/ml heparin, 1 mM DTT, 10 ~g/rnl yeast 
tRNA), poly(rU) (0.1 rng/ml), and heat-denatured radiolabeled RNA 
(1 x 105 to 5 x 10 s cpm, typically I x 10 -14 to 5 x 10 14 rnol). Following 
incubation at ambient emperature for 10 rnin, 2 I~1 of 50% glycerol 
was added, and the mixture was electrophoresed through a 5% native 
polyacrylarnide gel (79:1 acrylamide:bisacrylarnide) containing 5°/o 
glycerol and 0.5x TBE. Gels were electrophoresed at 210 V for 3 hr 
at 4°C, dried, and subjected to autoradiography. UV cross-linking ex- 
periments were carried out essentially as described by Gilmartin and 
Nevins (1989), except that the binding reactions (total volume, 10 I~1) 
were prepared as described above, prior to UV irradiation. Following 
RNase A treatment, proteins covalently bound to RNA were electro- 
phoresed through an 8O/o SDS-polyacrylamide gel and visualized by 
autoradiography. 
To determine the identity of proteins in the gel shift complexes (A 
and B in Figure 1), we prepared photoreactive, radiolabeled RNA by 
using an equirnolar mixture of 5-BrUTP and UTP (0.25 rnM each). 
Following incubation with embryonic extract and electrophoresis as 
described above, the gel was irradiated with 300 nrn UV light (Foto- 
dyne) as described by Molitor et al. (1990), at room temperature for 
30 rain. Gel slices containing protein-RNA complexes were incubated 
at 37°C for 3 hr in 300 p.I of buffer (6.7 mM Tris [pH 7.5], 6.7 rnM 
MgCI2, 50 rnM NaCI, 0.5 rnM DTT) containing 10 ~,g of RNase A. 
Reaction mixtures were then electrophoresed through a 10% SDS- 
polyacrylamide gel. For the lower complex (A in Figure 1), this proce- 
dure resulted in the covalent transfer of 32p to a protein that comigrates 
with the 55 kDa complex seen in conventional UV cross-linking experi- 
ments, We did not recover detectable levels of labeled protein following 
irradiation of the upper complex (B). 
Expression of Pum in COS Cells and Reticulocyte Lysstes 
Details of the construction of derivatives of pCMV4 (Andersson et al., 
1989) that direct pure expression are available on request. COS cells 
were transfected by standard procedures (Cullen, 1987). Soluble ex- 
tracts were prepared by harvesting cells 48 hr posttransfection, lysing 
them by sonication, and removing debris by centrifugation. Coupled 
in vitro transcription and translation using reticulocyte lysates was 
performed by using the TnT kit as described by the manufacturer 
(Promega). 
Pumilio Binds to hunchback mRNA 
755 
Analysis of NRE Function In Vivo 
Transformant lines bearing each modified hb gene were generated 
by microinjection into w "a recipient emb~os by use of standard tech- 
niques. For each mutant NRE, we analyzed the segmentation pattern 
in embryos from transformant females that were derived from at least 
three (and in most cases more) independent lines. 
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